Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 15Vincristine 13Prednisone 13Rituximab 12Doxorubicin 11Etoposide 10Radiotherapy 9Methotrexate 6Filgrastim 6Cytarabine 6Gemcitabine 5Cisplatin 5VAP-cyclo protocol 4Granulocyte Colony-Stimulating Factor 4ibritumomab tiuxetan 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Leucovorin 3Immunohistochemistry 3Ifosfamide 3Gene Expression Profiling 3Dexamethasone 3pegfilgrastim 2merphos 2fludarabine 2axicabtagene ciloleucel 2Watchful Waiting 2Specimen Handling 2Mesna 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large B-Cell, Diffuse × rasburicase × Clear all
NCT00057811 2014-09-19

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Children's Oncology Group

Phase 2 Completed
97 enrolled 13 charts
LymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡